ArticleClinical ophthalmology (Auckland, N.Z.)2021

Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.

David L Wirta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.